| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Sanare is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1997, the Indiana University Health family has grown to include an expanding network of partner hospitals across the state of Indiana. With several well-respected Centers of Excellence and a strong partnership with the Indiana University School of Medicine, IU Health is a leader in health care quality, medical innovation and patient satisfaction.
TytoCare Ltd. is a consumer-focused telehealth company, offering state-of-the-art, patented devices and platform that empower anyone, anywhere and anytime to perform a variety of medical examinations and seamlessly consult with a clinician. The company was founded by Dedi Gilad, Ofer Tzadik and industry experts in 2012. Investors include OrbiMed Advisors, Walgreens, Cambia Health Solutions, Fosun Pharma, LionBird, Teuza VC and others.
TAKE is an industry leader in providing the following services to Pharmaceutical companies such as: CDISC Services, where we offer the most effective data standardization solutions and consulting services. The OneClinical team under the leadership of a